UNIGE document Scientific Article
previous document  unige:21346  next document
add to browser collection
Title

The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation

Authors
Patel, Seema
Asthana, Sonal
Kawahara, Toshiyasu
Girgis, Safwat
Kneteman, Norman N.
Shapiro, A M James
Bigam, David L.
Published in Clinical Transplantation. 2010, vol. 24, no. 5, p. 695-700
Abstract BACKGROUND: There is a lack of data on the use of sirolimus after partial liver transplantation, especially regarding its impact on post-transplant regeneration. METHODS: We reviewed adult living donor transplantations, with de novo sirolimus (n = 7) and without sirolimus (n = 21). Liver biopsies were stained for KI-67, a proliferation marker. Controls included specimens with normal liver parenchyma (n = 13). RESULTS: Both groups had similar demographics, graft and patient survival and complication rates. During the first six wk and over the whole first year post-transplant, the use of sirolimus was associated with lower levels of hepatocyte proliferation compared to sirolimus-free patients, (overall, 0.3 [0-7.2] vs. 3 [0-49] KI-67 positive hepatocytes per high power field, p </= 0.05). The levels observed in the sirolimus group were similar to those seen in non-transplanted control patients with normal parenchyma (0.2 [0-1.3], p = NS). Post-transplant hepatocyte proliferation correlated with the serum levels of sirolimus (p </= 0.05), but not with those of tacrolimus or with the dose of mycophenolate mofetil (p = 0.9 and 0.3, respectively). CONCLUSIONS: These data suggest that sirolimus is associated with decreased post-transplant hepatocyte proliferation. The clinical significance of this observation remains to be fully determined.
Keywords AdolescentAdultAgedCells, CulturedFemaleGraft Rejection/*drug therapyHepatocytes/*cytology/*drug effectsHumansImmunosuppressive Agents/*therapeutic useLiver Regeneration/drug effects*Liver Transplantation*Living DonorsMaleMiddle AgedProspective StudiesRetrospective StudiesSirolimus/*therapeutic useTreatment OutcomeYoung Adult
Identifiers
PMID: 20002466
Full text
Structures
Research group Transplantation et hépatologie (905)
Citation
(ISO format)
TOSO, Christian et al. The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation. In: Clinical Transplantation, 2010, vol. 24, n° 5, p. 695-700. https://archive-ouverte.unige.ch/unige:21346

174 hits

0 download

Update

Deposited on : 2012-05-23

Export document
Format :
Citation style :